Aktiviteetteja vuodessa
Aktiviteetit
- 1 - 50 osumaa 156 tuloksesta
Hakutulokset
-
Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets
Antti Laurikka (Speaker), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Jari Laurikka (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets
Leevi Halonen (Speaker), Antti Pemmari (Contributor), Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
Meteorin-like protein as a novel factor and potential drug target in osteoarthritis
Katriina Vuolteenaho (Speaker), Anna Koskinen-Kolasa (Contributor), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor) & Eeva Moilanen (Contributor)
2 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1 in murine macrophages
Tiina Lehtola (Contributor), Elina Nummenmaa (Contributor), Tiina Leppänen (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets
Antti Laurikka (Contributor), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Jari Laurikka (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
22 maalisk. 2023 → 24 maalisk. 2023Aktiviteetti: Konferenssiesitelmä
-
The glucocorticoid dexamethasone alleviates allergic inflammation through an MKP-1 dependent mechanism
Tiina Lehtola (Contributor), Elina Nummenmaa (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
22 maalisk. 2023 → 24 maalisk. 2023Aktiviteetti: Konferenssiesitelmä
-
Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study
Antti Laurikka (Speaker), Katriina Vuolteenaho (Contributor), Vesa Toikkanen (Contributor), Timo Rinne (Contributor), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Matti Tarkka (Contributor), Jari Laurikka (Contributor) & Eeva Moilanen (Contributor)
24 marrask. 2022 → 25 marrask. 2022Aktiviteetti: Konferenssiesitelmä
-
The glucocorticoid dexamethasone alleviates acute allergic inflammatory reaction through an MKP-1 dependent mechanism
Tiina Lehtola (Speaker), Elina Nummenmaa (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
24 marrask. 2022 → 25 marrask. 2022Aktiviteetti: Konferenssiesitelmä
-
Pinosylvin shifts macrophage polarization to support resolution of inflammation
Konsta Kivimäki (Speaker), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
25 marrask. 2021 → 26 marrask. 2021Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates fibroblast growth factor-2 expression in chondrocytes
Elina Nummenmaa (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Lauri Moilanen (Contributor), Riina Nieminen (Contributor), Teemu Moilanen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
25 marrask. 2021 → 26 marrask. 2021Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)
29 marrask. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes
E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), E Moilanen (Contributor), LJ Moilanen (Contributor), R Nieminen (Contributor), K Vuolteenaho (Contributor) & T Moilanen (Contributor)
29 marrask. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes
Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)
2 toukok. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
A Pemmari (Contributor), L Tuure (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)
2 toukok. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates fibroblast growth factor-2 (FGF-2) expression in chondrocytes
Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)
20 maalisk. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)
20 maalisk. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes
Elina Nummenmaa (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
A Pemmari (Speaker), L Tuure (Speaker), M Hämäläinen (Speaker), T Leppänen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
Adipokines and disease activity in patients with newly diagnosed inflammatory joint diseases
A Kononoff (Speaker), K Vuolteenaho (Speaker), M Hämäläinen (Speaker), H Kautiainen (Speaker), P Elfving (Speaker), E Savolainen (Speaker), L Arstila (Speaker), H Niinisalo (Speaker), J Rutanen (Speaker), O Marjoniemi (Speaker), E Moilanen (Speaker) & O Kaipiainen-Seppänen (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis
Mari Hämäläinen (Contributor), Lauri Lehtimäki (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Elina Nummenmaa (Contributor) & Katriina Vuolteenaho (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis
Mari Hämäläinen (Speaker), Lauri Männistö (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker), Elina Nummenmaa (Speaker) & Katriina Vuolteenaho (Speaker)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), L Moilanen (Contributor), R Nieminen (Contributor), T Moilanen (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
M Scotece (Contributor), A Koskinen-Kolasa (Contributor), A Pemmari (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis
A Pemmari (Speaker), T Syvänen (Speaker), M Hämäläinen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)
26 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor and drug target in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)
26 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates interleukin-6 expression in chondrocytes
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis (OA): Retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in OA patients
M Scotece (Contributor), A Koskinen-Kolasa (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis
Antti Pemmari (Speaker), Mari Hämäläinen (Speaker), Tiina Leppänen (Speaker), Eeva Moilanen (Speaker) & Katriina Vuolteenaho (Speaker)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients
M Scotece (Contributor), A Koskinen-Kolasa (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)
21 maalisk. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes
E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), LJ Moilanen (Contributor), RM Nieminen (Contributor), T Moilanen (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)
21 maalisk. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
M Laavola (Speaker), T Leppänen (Speaker), M Hämäläinen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker), R Nieminen (Speaker) & E Moilanen (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients
Eeva Moilanen (Speaker) & Katriina Vuolteenaho (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes
E Nummenmaa (Speaker), M Hämäläinen (Speaker), A Pemmari (Speaker), L Moilanen (Speaker), R Nieminen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients
K Vuolteenaho (Contributor), A Koskinen-Kolasa (Contributor), M Laavola (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by RNA-Seq-based genome wide expression analysis
Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
TRPA1 elicits inflammatory effects in chondrocytes and its expression is downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate
E Nummenmaa (Speaker), M Hämäläinen (Speaker), LJ Moilanen (Speaker), E-L Paukkeri (Speaker), RM Nieminen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)
10 heinäk. 2017Aktiviteetti: Konferenssiesitelmä
-
High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients
Katriina Vuolteenaho (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)
27 huhtik. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) triggers catabolic and inflammatory effects in human chondrocytes and its expression in downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)
27 huhtik. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate in human chondrocytes
Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)
22 maalisk. 2017Aktiviteetti: Konferenssiesitelmä
-
High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients
K Vuolteenaho (Contributor), A Koskinen-Kolasa (Contributor), M Laavola (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)
22 maalisk. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes
Elina Nummenmaa (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)
27 tammik. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes and mediates cartilage destruction and joint pain in the MIA-model of osteoarthritis
E Nummenmaa (Contributor), LJ Moilanen (Contributor), M Hämäläinen (Contributor), E-L Paukkeri (Contributor), R Nieminen (Contributor), T Moilanen (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)
11 marrask. 2016Aktiviteetti: Konferenssiesitelmä
-
Adipokines leptin, adiponectin and resistin and their associations to MMPs, IL-6, COMP and radiographic severity of OA
Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)
31 maalisk. 2016Aktiviteetti: Konferenssiesitelmä
-
TRPA1 mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis
LJ Moilanen (Contributor), M Hämäläinen (Contributor), E Nummenmaa (Contributor), P Ilmarinen (Contributor), K Vuolteenaho (Contributor), RM Nieminen (Contributor), L Lehtimäki (Contributor) & E Moilanen (Contributor)
31 maalisk. 2016Aktiviteetti: Konferenssiesitelmä